Skip to main content

Table 1 Morphometric and demographic data and surgical procedures

From: Early administration of levosimendan is associated with improved kidney function after cardiac surgery – a retrospective analysis

 

Levo OR

Levo ICU

Pvalue

(n = 28)

(n = 18)

Age (years)

66 ± 10

67 ± 11

0.535

Weight (kg)

82.1 ± 15.9

81.5 ± 15.0

0.928

Height (m)

1.76 ± 0.1

1.72 ± 0.1

0.167

Body mass index (kg/m2)

26.3 ± 3.9

27.9 ± 5.0

0.286

Sex (men/women)

22/6

13/5

0.622

Procedure

   

CABG

15

5

0.114

VR

5

8

0.051

CABG + VR

8

5

0.953

NYHA III/IV

25

16

0.966

Coronary artery disease

23

13

0.426

LVEF (%)

31 ± 12

36 ± 15

0.233

COPD

9

5

0.754

Peripheral vascular disease

7

5

0.834

Atrial fabrillation

17

9

0.474

Hyperlipidaemia

8

8

0.270

Nicotine abuse

6

1

0.144

Pulmonary arterial hypertension

12

10

0.400

Arterial hypertension

13

9

0.813

Diabetes mellitus

16

12

0.518

  1. Data are expressed as mean ± SD, numbers or percentage. CABG, coronary arterial bypass grafting; VR, valve reconstrution and/or replacement; NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; COPD, chronic obstructive pulmonary disease.